U.S. pharmaceutical company Eli Lilly plans to disclose the topline results of its phase 3 clinical trial for remternemab, a new drug candidate developed as a successor to its Alzheimer’s treatment ...

New research shows that aging blood can accelerate Alzheimer’s-like changes in the brain, while younger blood may offer ...

Alzheimer's disease (AD) is a serious neurodegenerative disease largely affecting older adults. Apart from age, it also shows ...

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein transthyretin that cause ...

Obesity may quietly fast-forward Alzheimer’s disease, with blood tests revealing the change years earlier than expected.

“Microplastics actually weaken the blood-brain barrier, making it leaky. “Once that happens, immune cells and inflammatory ...

Protein aggregation exhibits a dual role in biology, especially in neural systems. While pathogenic aggregates of proteins such as Aβ, tau, and α-synuclein ...

Alzheimer’s disease, the most common form of dementia, may be influenced by factors circulating in the blood. In mouse experiments, blood from aged animals accelerated amyloid plaque buildup and ...